Literature DB >> 15342014

The genetics of HLA-associated disease.

Charles E Larsen1, Chester A Alper.   

Abstract

Type 1 diabetes mellitus (T1D) remains the most intensively studied, and thus the best paradigm, of MHC-associated diseases. Accumulating evidence suggests that MHC susceptibility for T1D is recessive, with susceptibility alleles more common than protective alleles. Updated allele-level and nucleotide sequence analysis of MHC class II T1D susceptibility markers of conserved extended haplotypes underscore the uncertainty surrounding the actual T1D MHC susceptibility locus. Recent studies have established that disease concordance in dizygotic twins is the same as that in siblings generally, for both T1D and the MHC-associated autoimmune disease gluten-sensitive enteropathy, leaving little room for a differential environmental trigger. Epigenetic mechanisms are probably involved in many MHC-associated phenomena, including autoimmunity, and appear to be the best explanation for incomplete penetrance.

Entities:  

Mesh:

Year:  2004        PMID: 15342014     DOI: 10.1016/j.coi.2004.07.014

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  33 in total

1.  A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.

Authors:  Marcos M Miretti; Emily C Walsh; Xiayi Ke; Marcos Delgado; Mark Griffiths; Sarah Hunt; Jonathan Morrison; Pamela Whittaker; Eric S Lander; Lon R Cardon; David R Bentley; John D Rioux; Stephan Beck; Panos Deloukas
Journal:  Am J Hum Genet       Date:  2005-03-01       Impact factor: 11.025

2.  Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes.

Authors:  Chester A Alper; Zaheed Husain; Charles E Larsen; Devendra P Dubey; Rosanne Stein; Caitlin Day; Alissa Baker; Huriya Beyan; Mohammed Hawa; Thomas O Ola; R David Leslie
Journal:  J Autoimmun       Date:  2006-10-06       Impact factor: 7.094

Review 3.  Genetic epidemiology of type 1 diabetes.

Authors:  Andrew D Paterson
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810

4.  Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.

Authors:  Erik Evensen; Diane Joseph-McCarthy; Gregory A Weiss; Stuart L Schreiber; Martin Karplus
Journal:  J Comput Aided Mol Des       Date:  2007-07-27       Impact factor: 3.686

5.  Update on islet cell transplantation for type 1 diabetes.

Authors:  Avinash Agarwal; Kenneth L Brayman
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

6.  Immunoglobulins and complement factor C4 in adult rhinosinusitis.

Authors:  M Seppänen; J Suvilehto; M-L Lokki; I-L Notkola; A Järvinen; H Jarva; I Seppälä; O Tahkokallio; H Malmberg; S Meri; V Valtonen
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

7.  Predicting multiallelic genes using unphased and flanking single nucleotide polymorphisms.

Authors:  Shuying S Li; Hongwei Wang; Anajane Smith; Bo Zhang; Xinyi Cindy Zhang; Gary Schoch; Daniel Geraghty; John A Hansen; Lue Ping Zhao
Journal:  Genet Epidemiol       Date:  2010-12-31       Impact factor: 2.135

Review 8.  Smell and autoimmunity: a comprehensive review.

Authors:  Carlo Perricone; Netta Shoenfeld; Nancy Agmon-Levin; Caterina de Carolis; Roberto Perricone; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

9.  Development of dense microsatellite markers in the entire SLA region and evaluation of their polymorphisms in porcine breeds.

Authors:  Maiko Tanaka; Asako Ando; Christine Renard; Patrick Chardon; Michiko Domukai; Naohiko Okumura; Takashi Awata; Hirohide Uenishi
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

Review 10.  The "A, B and C" of Her-2 DNA vaccine development.

Authors:  Wei-Zen Wei; Jennifer Jacob; Olga Radkevich-Brown; Paula Whittington; Yi-chi M Kong
Journal:  Cancer Immunol Immunother       Date:  2008-02-14       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.